SI1140117T1 - Aciclovir compositions containing dimethicone - Google Patents

Aciclovir compositions containing dimethicone

Info

Publication number
SI1140117T1
SI1140117T1 SI9930324T SI9930324T SI1140117T1 SI 1140117 T1 SI1140117 T1 SI 1140117T1 SI 9930324 T SI9930324 T SI 9930324T SI 9930324 T SI9930324 T SI 9930324T SI 1140117 T1 SI1140117 T1 SI 1140117T1
Authority
SI
Slovenia
Prior art keywords
aciclovir
compositions containing
containing dimethicone
dimethicone
compositions
Prior art date
Application number
SI9930324T
Other languages
English (en)
Slovenian (sl)
Inventor
Parbinder Singh GlaxoSmithKline CHEEMA
David Glaxosmithkline Gower
Andrew David GlaxoSmithKline MOUNTER
Timothy Giles GlaxoSmithKline SABEY
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10845017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1140117(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of SI1140117T1 publication Critical patent/SI1140117T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9930324T 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone SI1140117T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9828620.6A GB9828620D0 (en) 1998-12-23 1998-12-23 Medicaments
PCT/EP1999/010155 WO2000038695A2 (en) 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone
EP99965505A EP1140117B1 (de) 1998-12-23 1999-12-21 Dimeticon enthaltende aciclovirzusammensetzungen

Publications (1)

Publication Number Publication Date
SI1140117T1 true SI1140117T1 (en) 2003-12-31

Family

ID=10845017

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930324T SI1140117T1 (en) 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone

Country Status (27)

Country Link
EP (1) EP1140117B1 (de)
JP (1) JP4145493B2 (de)
KR (1) KR100707329B1 (de)
CN (2) CN1191834C (de)
AR (1) AR021993A1 (de)
AT (1) ATE236644T1 (de)
AU (1) AU768989B2 (de)
BR (1) BR9916524A (de)
CA (1) CA2356895A1 (de)
CZ (1) CZ295770B6 (de)
DE (2) DE69906796T2 (de)
DK (1) DK1140117T3 (de)
ES (1) ES2196910T3 (de)
GB (2) GB9828620D0 (de)
HK (2) HK1039275A1 (de)
HU (1) HU230542B1 (de)
IL (2) IL143833A0 (de)
NO (1) NO322090B1 (de)
NZ (1) NZ512457A (de)
PE (1) PE20001351A1 (de)
PL (1) PL196629B1 (de)
PT (1) PT1140117E (de)
SI (1) SI1140117T1 (de)
TR (1) TR200102482T2 (de)
TW (1) TW585768B (de)
WO (1) WO2000038695A2 (de)
ZA (1) ZA200105071B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
CA2741028A1 (en) * 2008-10-21 2010-04-29 Novodermix International Limited Composition for treatment of epithelial tissue
WO2012107575A1 (en) * 2011-02-10 2012-08-16 Moberg Derma Ab Novel formulations for dermal, transdermal and mucosal use 2
WO2015082172A1 (en) * 2013-12-03 2015-06-11 Zzip Ag Polydimethylsiloxane for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
ZA903060B (en) * 1989-04-24 1991-12-24 Syntex Inc Topical antiviral pharmaceutical composition containing a nonionic surfactant
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FR2728167A1 (fr) * 1994-12-15 1996-06-21 Cird Galderma Composition cosmetique ou dermatologique sous forme d'une emulsion eau dans huile a teneur elevee en hydroxyacides
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Also Published As

Publication number Publication date
DE69906796T2 (de) 2004-01-29
CZ295770B6 (cs) 2005-11-16
CN100415237C (zh) 2008-09-03
JP2002542149A (ja) 2002-12-10
WO2000038695A2 (en) 2000-07-06
NO322090B1 (no) 2006-08-14
AU768989B2 (en) 2004-01-15
KR20010099932A (ko) 2001-11-09
PL349505A1 (en) 2002-07-29
DE29924428U1 (de) 2003-08-28
HUP0104594A2 (en) 2002-06-29
ATE236644T1 (de) 2003-04-15
NO20013103L (no) 2001-08-20
HU230542B1 (hu) 2016-11-28
ES2196910T3 (es) 2003-12-16
BR9916524A (pt) 2001-10-02
GB2362105B (en) 2003-06-18
IL143833A0 (en) 2002-04-21
NO20013103D0 (no) 2001-06-21
ZA200105071B (en) 2002-09-20
KR100707329B1 (ko) 2007-04-13
DE69906796D1 (de) 2003-05-15
CN1191834C (zh) 2005-03-09
AU2099700A (en) 2000-07-31
PL196629B1 (pl) 2008-01-31
HUP0104594A3 (en) 2002-12-28
EP1140117A2 (de) 2001-10-10
TR200102482T2 (tr) 2003-03-21
CN1539421A (zh) 2004-10-27
HK1067548A1 (en) 2005-04-15
AR021993A1 (es) 2002-09-04
NZ512457A (en) 2003-10-31
WO2000038695A3 (en) 2000-10-26
JP4145493B2 (ja) 2008-09-03
DK1140117T3 (da) 2003-07-21
PT1140117E (pt) 2003-08-29
IL143833A (en) 2006-12-31
CZ20012332A3 (cs) 2001-12-12
CA2356895A1 (en) 2000-07-06
HK1039275A1 (zh) 2002-04-19
GB2362105A (en) 2001-11-14
EP1140117B1 (de) 2003-04-09
PE20001351A1 (es) 2000-12-14
TW585768B (en) 2004-05-01
GB9828620D0 (en) 1999-02-17
GB0117795D0 (en) 2001-09-12
CN1334737A (zh) 2002-02-06

Similar Documents

Publication Publication Date Title
PL341372A1 (en) Cellecoxibe containing compositions
GB9804720D0 (en) Shampoo compositions
GB9808310D0 (en) Shampoo compositions
GB9822518D0 (en) Antiperspirant compositions
GB9804725D0 (en) Shampoo compositions
PL343892A1 (en) Mousse-forming shampoo compositions
HU9901606D0 (en) Pharmaceutical compositions
HUP0103507A2 (hu) 2-Kinolonokat tartalmazó gyógyászati készítmények
GB9827996D0 (en) Pharmaceutical Compositions
GB9824024D0 (en) Shampoo compositions
PL343627A1 (en) Medicinal compositions
GB9809213D0 (en) Pharmaceutical compositions
PL334568A1 (en) Paroxetin containing compositions
GB9726970D0 (en) Shampoo compositions
PL338922A1 (en) Oral compositions
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
GB9812819D0 (en) Dentifrice compositions
GB2362105B (en) Aciclovir compositions containing dimethicone
IL137403A0 (en) Pharmaceutical compositions
GB9818123D0 (en) Cosmetic compositions
GB9818016D0 (en) Cosmetic compositions
GB9806487D0 (en) Pharmaceutical compositions
HU9803024D0 (en) Oral compositions containing ubidekarenone
PL330972A1 (en) Tetrahydrolypstatin containing compositions
GB9804717D0 (en) Shampoo compositions